JOHN MICHAEL GONZALEZ
JOHN MICHAEL GONZALEZ is named as a lobbyist in 28 lobbying reports we hold, filed by 1 registrant for 28 clients.
Earlier government jobs, as reported
A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.
- Chief of Staff, Rep. Melissa Bean (2005-2009); Chief of Staff, Rep. Chris Bell (2003-2005)
Registrants and clients
- TIBER CREEK GROUP · 28 reports
Clients: ALNYLAM PHARMACEUTICALS, INC.; AMGEN INC; ASTELLAS PHARMA US, INC.; ASTRAZENECA; CANADA LIFE REINSURANCE COMPANY; DEMOCRATIC MAJORITY FOR ISRAEL; ELEVANCE HEALTH, INC.; EMD SERONO, INC.; ENVIRONMENTAL DEFENSE ACTION FUND; FWD.US; GILEAD SCIENCES, INC.; GRID UNITED LLC; HANNOVER LIFE REASSURANCE COMPANY OF AMERICA; JAZZ PHARMACEUTICALS; MALARIA NO MORE; MERCK & CO., INC; MICROSOFT CORPORATION; MUNICH AMERICAN REASSURANCE COMPANY; PHRMA; SB ENERGY DEVCO (US), INC.; SB GROUP US DBA SOFTBANK GROUP US, INC.; TAKEDA PHARMACEUTICALS AMERICA, INC.; THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY; TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY); TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF GENENTECH, INC.); TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS); U.S. CHAMBER OF COMMERCE FKA U.S. CHAMBER OF COMMERCE-INSTITUTE FOR LEGAL REFORM; WE WORK FOR HEALTH.
Bills named where this lobbyist is listed, and how the House and the Senate voted
26 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1109Litigation Transparency Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1672Maintaining Investments in New Innovation Act | Introduced | No recorded vote in our record |
| H.R. 2675Protecting Our Courts from Foreign Manipulation Act | Reported by committee | No recorded vote in our record |
| H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act | Introduced | No recorded vote in our record |
| H.R. 4393DIGNIDAD (Dignity) Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 5526Biosimilar Red Tape Elimination Act | Introduced | No recorded vote in our record |
| H.R. 6048NDO Fairness Act of 2025 | Passed the House | No recorded vote in our record |
| H.R. 6509SAFE Drugs Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 7786AI Fraud Accountability Act | Introduced | No recorded vote in our record |
| H.R. 8398Guidelines for Use, Access, and Responsible Disclosure of Financial Data Act | Introduced | No recorded vote in our record |
| H.R. 8413SECURE Data Act | Introduced | No recorded vote in our record |
| H.R. 8595Making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes. | Passed the House | No recorded vote in our record |
| H.R. 8800National Defense Authorization Act for Fiscal Year 2027 | Passed the House | No recorded vote in our record |
| H.R. 8857Next GEN Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9102BINSA Act | Introduced | No recorded vote in our record |
| S. 1748 | Not checked yet | No recorded vote in our record |
| S. 1862ORPHAN Cures Act | Introduced | No recorded vote in our record |
| S. 1954Biosimilar Red Tape Elimination Act | Reported by committee | No recorded vote in our record |
| S. 2658Medication Affordability and Patent Integrity Act | Reported by committee | No recorded vote in our record |
| S. 3180Protecting Our Courts from Foreign Manipulation Act of 2025 | Introduced | No recorded vote in our record |
| S. 3348Dream Act of 2025 | Introduced | No recorded vote in our record |
| S. 3663NDO Fairness Act of 2026 | Introduced | No recorded vote in our record |
| S. 3982AI Fraud Accountability Act of 2026 | Introduced | No recorded vote in our record |
| S. 4894FUSE Act | Introduced | No recorded vote in our record |
Issues named: Medicare/Medicaid (12), Health Issues (10), Insurance (4), Taxation/Internal Revenue Code (4), Trade (domestic/foreign) (3), Budget/Appropriations (2), Defense (2), Environment/Superfund (2), Foreign Relations (2), Law Enforcement/Crime/Criminal Justice (2), Financial Institutions/Investments/Securities (1), Immigration (1), and 4 mores.
Every report
| Client | Registrant | Kind, as filed | Posted | Report |
|---|---|---|---|---|
| U.S. CHAMBER OF COMMERCE FKA U.S. CHAMBER OF COMMERCE-INSTITUTE FOR LEGAL REFORMTorts, Law Enforcement/Crime/Criminal Justice, Defense | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| MICROSOFT CORPORATIONLabor Issues/Antitrust/Workplace, Law Enforcement/Crime/Criminal Justice | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)Medicare/Medicaid, Health Issues | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ELEVANCE HEALTH, INC.Medicare/Medicaid | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF GENENTECH, INC.)Medicare/Medicaid, Health Issues | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| TAKEDA PHARMACEUTICALS AMERICA, INC.Medicare/Medicaid | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| PHRMAMedicare/Medicaid, Trade (domestic/foreign) | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| MERCK & CO., INCMedicare/Medicaid, Trade (domestic/foreign), Health Issues | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| EMD SERONO, INC.Health Issues, Medicare/Medicaid | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| JAZZ PHARMACEUTICALSHealth Issues, Medical/Disease Research/Clinical Labs | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ASTRAZENECADefense | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| MALARIA NO MOREForeign Relations, Budget/Appropriations | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| AMGEN INCMedicare/Medicaid, Health Issues | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ALNYLAM PHARMACEUTICALS, INC.Medicare/Medicaid | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| SB GROUP US DBA SOFTBANK GROUP US, INC.Science/Technology | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| SB ENERGY DEVCO (US), INC.Taxation/Internal Revenue Code | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| MUNICH AMERICAN REASSURANCE COMPANYTaxation/Internal Revenue Code, Insurance | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| HANNOVER LIFE REASSURANCE COMPANY OF AMERICAInsurance, Taxation/Internal Revenue Code | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| CANADA LIFE REINSURANCE COMPANYInsurance, Taxation/Internal Revenue Code | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANYInsurance, Financial Institutions/Investments/Securities | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ENVIRONMENTAL DEFENSE ACTION FUNDEnvironment/Superfund | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| GILEAD SCIENCES, INC.Health Issues, Medicare/Medicaid | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ASTELLAS PHARMA US, INC.Health Issues, Medicare/Medicaid | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| WE WORK FOR HEALTHHealth Issues | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)Medicare/Medicaid, Health Issues, Trade (domestic/foreign) | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| GRID UNITED LLCEnvironment/Superfund, Budget/Appropriations | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| FWD.USImmigration | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| DEMOCRATIC MAJORITY FOR ISRAELForeign Relations | TIBER CREEK GROUP | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this lobbyist reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.